) and a diploid, Epstein-Barr virus transformed lymphoblastoid cell line of cord blood origin were transplanted into the brain (i.c.) of nude mice as well as into the muscle (i.m.) in a parallel experiment. After the tumors had developed, they were treated by intraperitoneal application of a panel of cytostatic drugs given as monotherapy. Parameters of treatment success were reduction of tumor size (i.m.) and prolongation of survival time (i.c.) compared to an untreated control group. Therapy results in both transplantation routes were analyzed and compared using the Student's t-test. Sensitivity and resistance of the cell lines tested in the i.c. system were in good accordance with results in the i.m. Bd.365,S.1291 Bd.365,S. -1308 Bd.365,S. ,1984 . The amino acid sequence of the HLA-DR2 antigen was determined using micromethods. It consists of two no~covalently associated subunits: an a chain of molecular weight 34 kd(229 amino acid residues) and a B chain of 29 kd (237 amino acid residues). The membrane glycoproteins are organized in three parts: first,the long N-terminal part encompassing 191 and 198 amino acid residues of the a and 8 chain, respectively; second, hydrophobic regions comprising 23 residues in both heavy (a) and light (g) chain wieh penetrate the cell membrane and third, a basic hydrophilic short C-terminus of 15 and 16 amino acids immersing into the cytoplasm. The higher molecular weight of the a chain originates from two N-glycosidically linked side chains in $ontrast to only one carbohydrate moiety attached to the extracellular part of the B chain. The determination of the nearly complete amino acid sequence of the DC i a chain as well as the characterisation of at least 7 class II B-chains provides an insight into the isotypic complexity of human class II antiqens. In addition 4 monoelonal antibodies (moAb) were prepared and characterized. MoAb 35.12 and moAb 43.7 specific for p 34 prooved to be different after 2D separation of p 34. After IEF of p 34 moAb 43.7 prooved to react with all a chains, whereas moAb 35.12 yielded a reaction only with a single a chain. MoAb BE ii.i0 and BE 44.23 prooved to be specific for p 29; moAb BE 11.10 showed reaction with a single band of p 29, moAb 44. Previous studies have demonstrated that cells of B-chronic lymphatic leukemia (B-CLL) develop both phenotypic and biochemical characteristics of hairy cell leukemia (HCL) when incubated with phorbol ester (TPA). We have investigated the myc-l-oncogene-expression in B-CLL and in HCL, the change in enzyme pattern and expression of the Tac-antigen of B-CLL after incubation with TPA. 6 patients with B-CLL, 6 patients with HCL and 3 controls were studied. The B-CLL cells were incubated with or without (controls) 2 nM TPA at 37~ for 96 hours. Expression of the myc-l-oncogene was tested in HCL and in white blood cells from healthy donors. Concerning the myc-l-oncogene expression no difference could be seen between HCL and controls. However, in 3 out of the 6 cases of B-CLL, myc-l-expression was 4-5 fold higher than in HCL and in the controls. After treatment with TPA an increase in cells positive for tartrate resistant acid phosphatase, in Tac-antigen expression and also in purine nucleoside phosphorylase (PNP) activity could be found, indicating a phenotypic change from a B-CLL to a HCL pattern. The myc-l-oncogene expression, however, remained unchanged, so that myc-i was further overexpressed in 3 cases of B-CLL. Conclusions: i. HCL is characterized by a myc-l-oncogene expression similar to white blood cells from healthy controis. 2. In 3 of the 6 cases of B-CLL, an overexpression of myc-l-oncogene was found. 3. Incubation of BrCLL with TPA causes changes in Tac-antigen, in TRAP expression and in PNP similar to the characteristics of HCL. However the overexpression of myc-i is not altered by incubation with 2 nM TPA. Thus only "HCL-like"-cells but not true HCL could be obtainedfrom B-CLL by incubation with TPA.
